Infanrix Hexa Vaccine
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Infanrix Hexa Vaccine is a hexavalent combination vaccine for infants and toddlers. Its labelling describes it for primary immunisation against diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, invasive disease caused by Haemophilus influenzae type b, and hepatitis B. It is described as prompting the immune system to produce protective antibodies and is given by a healthcare professional as an intramuscular injection.
Product Information
The following description reflects information associated with the hexavalent DTaP-IPV-Hib-HepB combination vaccine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the prevention of diphtheria, tetanus, and pertussis (whooping cough)
- Described for the prevention of poliomyelitis
- Described for the prevention of invasive Haemophilus influenzae type b disease
- Described for the prevention of hepatitis B infection
Described Dosage & Administration
- Administered only by a doctor or nurse as an intramuscular injection — not self-administered
- Given as a multi-dose course; the schedule set by the healthcare provider should be followed
- All doses in the course should be completed for the vaccine to work as intended
Described Side Effects
Commonly described side effects include:
- Irritability and restlessness
- Loss of appetite
- Injection-site reactions (pain, swelling, redness)
- Unusual crying
- Fever
- Sleepiness
These are described as completely temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The doctor should be told if the child has any medical condition or is currently on any medicine
- Any previous allergic reaction to a vaccine or vaccine component should be disclosed beforehand
- Administration may be delayed during an acute febrile illness, per manufacturer guidance
- Any persistent or severe side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it is a hexavalent combination vaccine for primary immunisation of infants against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b disease, and hepatitis B. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling states it is administered by a doctor or nurse as an intramuscular injection, as a multi-dose course on the schedule set by the healthcare provider. All doses should be completed.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.